This inventor holds 2 USPTO granted patents. Top assignees: Egis Gyogyszergyar Rt., Schering Aktiengesellschaft. Active years: 1998-2003.
Company Filing History:
Years Active: 1998-2003
Title: Gizella Abraham: Innovator in Pharmaceutical Chemistry
Introduction
Gizella Abraham is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, her work focuses on innovative solutions for medical challenges.
Latest Patents
Gizella's latest patents include the development of condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors. These compounds, described by the formula I, are produced and utilized in pharmaceutical agents. Additionally, she has worked on 2,3-benzodiazepine derivatives that are substituted by one or two halogen atoms. These derivatives serve as non-competitive AMPA antagonists and are incorporated into pharmaceutical compositions. The process for creating these derivatives involves converting starting compounds that are also substituted by halogen groups.
Career Highlights
Throughout her career, Gizella has been associated with notable companies such as Egis Gyogyszergyar Rt. and Schering Aktiengesellschaft. Her work in these organizations has allowed her to advance her research and contribute to the development of important pharmaceutical products.
Collaborations
Gizella has collaborated with esteemed colleagues, including Sandor Solyom and Istvan Tarnawa. These partnerships have enriched her research and fostered innovation in her field.
Conclusion
Gizella Abraham stands out as a dedicated inventor in the pharmaceutical industry, with her innovative patents paving the way for new therapeutic options. Her contributions continue to impact the field positively.